All News

MiMedx Announces Expectation To Exceed Top End of Fourth Quarter Revenue Guidance Of $88 Million

MARIETTA, Ga., Nov. 30, 2017 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare, announced today its preliminary expectation for fourth quarter of 2017 revenue to exceed the $88 million high end of […]

Rotation Medical Bioinductive Implant Promotes Consistent Rotator Cuff Healing, Mitigates Tear Progression

November 30, 2017 PLYMOUTH, Minn.–(BUSINESS WIRE)–Rotation Medical Inc., a medical device company focused on developing new technologies to treat rotator cuff disease, today announced results of a study published online in the Journal of Shoulder and Elbow Surgery that shows the company’s Bioinductive Implant consistently heals rotator cuff tears and mitigates tear progression. […]

PAVmed Files 510(k) Submission with FDA for CarpX™ Device to Treat Carpal Tunnel Syndrome

November 28, 2017 NEW YORK–(BUSINESS WIRE)–PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multiproduct medical device company, today announced that it has filed a 510(k) premarket notification submission with the U.S. Food and Drug Administration (FDA) for its CarpX™ minimally invasive device designed to treat carpal tunnel syndrome. “We are […]

Regentis Biomaterials Performs the First Cases in GelrinC Pivotal Study

PRINCETON, New Jersey and OR AKIVA, Israel, November 28, 2017 /PRNewswire/ — Regentis Biomaterials announced today the start of its Phase III pivotal clinical trial of GelrinC for the treatment of focal knee cartilage defects with successful surgery on three patients in the U.S. and Denmark. These procedures are part of a Food and Drug Adminstration […]

curasan Inc. announces Orthopedic Private Label Distribution Agreement

Kleinostheim, Germany / Research Triangle Park, NC, USA, November 2, 2017 – curasan Inc., the US-subsidiary of curasan AG (ISIN DE0005494538), a leading medical supplier specializing in dental and orthopedic biomaterials, announced a private label distribution agreement with Xtant Medical (NYSE:XTNT Belgrade, Montana USA), a leader in the development and […]

curasan signs new cooperation with Implantcast for the DACH-region

Kleinostheim, 30 November 2017 – curasan AG (ISIN DE0005494538), a leading specialist for medical products in the field of orthobiologics, has signed an exclusive distribution agreement with Implantcast GmbH, Buxtehude, Germany. Already starting mid-December the worldwide acting orthopedics company, specialized on primary-, revision- and tumor endoprosthesis will market curasan AG’s bone […]

Scientists Race To Regrow Lost Knee Cartilage

Nov. 27, 2017 – By Kathleen Doheny/WebMD Health News  Bad knees sideline athletes and mere mortals alike.About 14 million Americans have osteoarthritis of the knees severe enough to cause pain and inflammation, according to the Arthritis Foundation, and more people are getting the condition — also known as OA — as they age. As the knee’s natural cushioning […]

Spinal Elements Announces Headquarters And CEO Changes

MARIETTA, GA. (PRWEB) NOVEMBER 28, 2017 Spinal Elements, Inc. today announced plans to move its global headquarters to its Carlsbad, California location. Concurrent with this move, Jason Blain, co-founder of Spinal Elements and currently its President and COO, will assume the role of President and CEO. This change is effective immediately. […]

EIT Emerging Implant Technologies Announces First Cases Completed Successfully by Top Surgeons in the United States

ROSWELL, GA. (PRWEB) NOVEMBER 28, 2017 Emerging Implant Technologies GmbH (EIT), a German medical device manufacturer exclusively focused on creating innovative technologies for spinal application by utilizing additive manufacturing, announces that it has now performed the first surgeries in the United States and is able to offer all interbody products for […]

Kuros Biosciences’ Chief Medical Officer to Retire

Schlieren (Zurich), Switzerland, November 28, 2017 Kuros announced today that its Chief Medical Officer, Dr. Virginia Jamieson, has reached retirement age and will retire from full-time employment with effect as of May 31, 2018. Her succession will be announced in due course. Dr. Joost de Bruijn, appointed CEO of Kuros […]

© 2025 MedDeviceJobs.com Powered by Careerleaf
v.4.6.4